SCHEMBL6761476

SCHEMBL6761476

COc1ccc2c(c1Cl)CCN[C@]21CC[C@H](C(=O)OC)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 2/20 0.42
HTR2B P41595 2/20 0.42
HTR2A P28223 1/20 0.42
ALDH1A1 P00352 3/20 0.34
PKM P14618 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
NOTUM Q6P988 1/20 0.32
PDE4A P27815 2/20 0.32
TAS1R3 Q7RTX0 1/20 0.32
TAS1R1 Q7RTX1 1/20 0.32
MAPKAPK2 P49137 1/20 0.32
ACACB O00763 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
MCOLN3 Q8TDD5 1/20 0.31
CYP1A2 P05177 1/20 0.31
CHRNA7 P36544 1/20 0.31
HTR3A P46098 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6761480 1.00 HTR2C (0.42) HTR2CHTR2BHTR2AALDH1A1PKM
SCHEMBL6761966 0.90 HTR2C (0.43) HTR2CHTR2BHTR2AALDH1A1PKM
SCHEMBL6761968 0.90 HTR2C (0.43) HTR2CHTR2BHTR2AALDH1A1PKM
SCHEMBL6757328 0.68 PKM (0.38) ALDH1A1PKMMEN1KMT2APDE4A
SCHEMBL6764437 0.67 NPC1 (0.40) PKMHPGD
SCHEMBL6760141 0.64 KDM1A (0.41) HTR2CHTR2BHTR2AMAPKAPK2
SCHEMBL6760145 0.64 KDM1A (0.41) HTR2CHTR2BHTR2AMAPKAPK2
SCHEMBL25430538 0.63 KDM4E (0.47) HTR2CHTR2BHTR2AALDH1A1NOTUM
SCHEMBL30471872 0.63 KDM4E (0.47) HTR2CHTR2BHTR2AALDH1A1NOTUM
SCHEMBL10983820 0.62 CYP1A2 (0.61) CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040106635-A1 having small-conductance potassium channel (SK) blocking activity TANABE SEIYAKU CO., LTD. (JP) 2004-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106635-A1 having small-conductance potassium channel (SK) blocking activity KCNN1, KCNN2, KCNN3 HTR2C 3742/4885HTR2B 2519/4885HTR2A 3301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.